Combination therapy for optimum glycaemic control : a randomized open label trial comparing rosiglitazone with combination sulphonylureas and metformin tablets in type 2 diabetes mellitus
Background As it is often difficult to achieve and maintain glycaemic goals, multiple drug therapy is eventually required in most patients. Combination therapy, involving an insulin secretagogue and an insulin sensitizer, can address the metabolic effect of this disease. The use of two sensitize...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2006
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/47636/1/Combination%20Therapy%20For%20Optimum%20Glycaemic%20Control%20A%20Randomized%20Open%20Label%20Trial%20Comparing%20Rosiglitazone%20With%20Combination%20Sulphonylureas%20And%20Metformin%20Tablets%20In%20TYPE%202%20Diabetes%20Mellitus-24%20pages.pdf http://eprints.usm.my/47636/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
http://eprints.usm.my/47636/1/Combination%20Therapy%20For%20Optimum%20Glycaemic%20Control%20A%20Randomized%20Open%20Label%20Trial%20Comparing%20Rosiglitazone%20With%20Combination%20Sulphonylureas%20And%20Metformin%20Tablets%20In%20TYPE%202%20Diabetes%20Mellitus-24%20pages.pdfhttp://eprints.usm.my/47636/